数字乳腺断层合成筛查乳腺癌:初始获益是否持续?
该回顾性研究比较数字乳腺断层合成(DBT)与二维数字乳腺摄影(DM)在人群层面及个体首次筛查后的长期筛查性能。DBT组异常解读率持续降低、特异度持续升高,但癌检出率在DBT与DM组间无差异,最高癌检出率见于女性首次DBT检查。
要点
- DBT筛查的异常解读率降低和特异度升高在首次筛查后持续存在。
- DBT与DM的癌检出率无差异(4.6-5.8/1000次检查)。
- 女性首次DBT检查的癌检出率最高(6.1/1000次检查)。
核心结论
- DBT筛查降低假阳性检查和提高特异度的获益在个体层面首次筛查轮次后持续存在。
研究设计与样本
- 回顾性综述,纳入DBT实施前(2008年3月至2011年2月,DM组)及实施后5年(2013年1月至2017年12月,DBT1-DBT5组)的筛查乳腺摄影。
- DM组包含55 086名女性的99 582次检查(平均年龄57.3岁±11.6);DBT组包含76 276名女性的205 048次检查(平均年龄58.2岁±11.2)。
- 接受DBT的患者还根据既往DBT检查次数分类,使用多变量逻辑回归模型比较性能指标。
诊断标准与关键数值
- DBT与DM组癌检出率无差异(4.6-5.8/1000次检查,P=.08至P=.95)。
- 女性首次DBT检查的癌检出率最高(6.1/1000次检查 vs 至少一次既往DBT检查的4.4-5.7/1000次检查,P=.001至P=.054)。
- 与DM组相比,DBT1组异常解读率更低(调整比值比[AOR] 0.85;P<.001),且在DBT2、DBT3和DBT5组中持续降低(P<.001至P=.02)。
- 与DM组相比,DBT1组特异度更高(AOR 1.20;P<.001),且在DBT2、DBT3和DBT5组中持续升高(P<.001至P=.004)。
- 异常解读率降低和特异度升高在首次检查后也持续存在(P<.001至P=.01)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Performance metrics with digital breast tomosynthesis (DBT) are based on early experiences. There is limited research on whether the benefits of DBT are sustained. Purpose To determine whether improved screening performance metrics with DBT are sustained over time at the population level and after the first screening round at the individual level. Materials and Methods A retrospective review was conducted of screening mammograms that had been obtained before DBT implementation (March 2008 to February 2011, two-dimensional digital mammography [DM] group) and for 5 years after implementation (January 2013 to December 2017, DBT1-DBT5 groups, respectively). Patients who underwent DBT were also categorized according to the number of previous DBT examinations they had undergone. Performance metrics were compared between DM and DBT groups and between patients with no previous DBT examinations and those with at least one prior DBT examination by using multivariable logistic regression models. Results The DM group consisted of 99 582 DM examinations in 55 086 women (mean age, 57.3 years ± 11.6 [standard deviation]). The DBT group consisted of 205 048 examinations in 76 276 women (mean age, 58.2 years ± 11.2). There were no differences in the cancer detection rate (CDR) between DM and DBT groups (4.6-5.8 per 1000 examinations, P = .08 to P = .95). The highest CDR was observed with a woman's first DBT examination (6.1 per 1000 examinations vs 4.4-5.7 per 1000 examinations with at least one prior DBT examination, P = .001 to P = .054). Compared with the DM group, the DBT1 group had a lower abnormal interpretation rate (AIR) (adjusted odds ratio [AOR], 0.85; P < .001), which remained reduced in the DBT2, DBT3, and DBT5 groups (P < .001 to P = .02). The reduction in AIR was also sustained after the first examination (P < .001 to P = .002). Compared with the DM group, the DBT1 group had a higher specificity (AOR, 1.20; P < .001), which remained increased in DBT2, DBT3, and DBT5 groups (P < .001 to P = .004). The increase in specificity was also sustained after the first examination (P < .001 to P = .01). Conclusion The benefits of reduced false-positive examinations and higher specificity with screening tomosynthesis were sustained after the first screening round at the individual level. © RSNA, 2020 See also the editorial by Taourel in this issue.
引用
- Bahl M, Mercaldo S, Dang PA, et al. Breast Cancer Screening with Digital Breast Tomosynthesis: Are Initial Benefits Sustained? Radiology. 2020. PMID: 32255414. doi:10.1148/radiol.2020191030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。